Indus Capital Partners, LLC Mei Pharma, Inc. Transaction History

Indus Capital Partners, LLC

  • $162 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$1.48 - $2.52 $80,864 - $137,687
-54,638 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$2.45 - $3.32 $1.55 Million - $2.1 Million
-631,513 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$1.92 - $4.1 $1.21 Million - $2.59 Million
631,513 New
631,513 $1.67 Million

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0
View Full List

About MEI Pharma, Inc.

MEIP Quotes by TradingView
  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Indus Capital Partners, LLC Portfolio

Follow Indus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indus Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email